vanadates has been researched along with sepharose in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alker, J; Nishigori, H; Toft, D | 1 |
| McKenzie, FR; Pouysségur, J; Viñals, F | 1 |
| Heldin, CH; Ostman, A; Persson, C; Shimizu, A | 1 |
3 other study(ies) available for vanadates and sepharose
| Article | Year |
|---|---|
Inhibition of progesterone receptor activation by vanadate.
Topics: Animals; Chickens; Female; In Vitro Techniques; Oviducts; Receptors, Progesterone; Sepharose; Vanadates; Vanadium | 1980 |
Growth factor-stimulated protein synthesis is inhibited by sodium orthovanadate.
Topics: Animals; Blotting, Western; Cell Cycle Proteins; Cell Line; Cricetinae; Dose-Response Relationship, Drug; Dual Specificity Phosphatase 1; Enzyme Inhibitors; Eukaryotic Initiation Factor-4E; Fibroblast Growth Factor 2; Growth Substances; Immediate-Early Proteins; Inhibitory Concentration 50; Peptide Initiation Factors; Phosphoprotein Phosphatases; Phosphorylation; Protein Binding; Protein Phosphatase 1; Protein Synthesis Inhibitors; Protein Tyrosine Phosphatases; Proto-Oncogene Proteins c-fos; Sepharose; Signal Transduction; Thrombin; Time Factors; Vanadates | 2001 |
Ligand stimulation reduces platelet-derived growth factor beta-receptor susceptibility to tyrosine dephosphorylation.
Topics: Agglutinins; Animals; Catalytic Domain; Cell Membrane; Cells, Cultured; Dimerization; Endothelium, Vascular; Enzyme Inhibitors; Ligands; Phosphorylation; Precipitin Tests; Protein Binding; Protein Phosphatase 1; Protein Structure, Tertiary; Protein Tyrosine Phosphatases; Receptor, Platelet-Derived Growth Factor beta; Recombinant Proteins; Sepharose; Swine; Transfection; Tyrosine; Vanadates | 2001 |